These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3782464)

  • 1. Blood levels of kinins in experimental allergic encephalomyelitis.
    Germain L; Barabe J; Galeano C
    J Neuroimmunol; 1986 Dec; 13(2):135-42. PubMed ID: 3782464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis.
    Germain L; Barabe J; Galeano C
    J Neurol Sci; 1988 Feb; 83(2-3):211-7. PubMed ID: 3356989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental allergic encephalomyelitis: a neurourological study.
    Germain L; Galeano C; Lamarche J; Elhilali MM
    Exp Neurol; 1988 Feb; 99(2):239-46. PubMed ID: 3338519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
    Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
    J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of des-Phe8-Arg9-bradykinin by enzyme-immunoassay--a useful parameter of plasma kinin release.
    Majima M; Ueno A; Sunahara N; Katori M
    Adv Exp Med Biol; 1989; 247B():331-5. PubMed ID: 2692413
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for the activation of the kallikrein-kinin system in experimental asbestosis.
    Barabé J; Sirois P; St-Pierre S
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):93-8. PubMed ID: 6145197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
    Audet R; Rioux F; Drapeau G; Marceau F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo.
    Bouthillier J; Deblois D; Marceau F
    Br J Pharmacol; 1987 Oct; 92(2):257-64. PubMed ID: 3676593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis.
    Du Clos TW; Mold C; Paterson PY; Alroy J; Gewurz H
    Clin Exp Immunol; 1981 Mar; 43(3):565-73. PubMed ID: 7026095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins.
    Pellacani A; Brunner HR; Nussberger J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S28-34. PubMed ID: 1282626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
    Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
    J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a radioimmunoassay for [DES-ARG9]-bradykinin.
    Odya CE; Moreland P; Stewart JM; Barabe J; Regoli DC
    Biochem Pharmacol; 1983 Jan; 32(2):337-42. PubMed ID: 6870961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors.
    Escher E; Laczkó E; Guillemette G; Regoli D
    J Med Chem; 1981 Dec; 24(12):1409-13. PubMed ID: 6118437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.
    Nakhostine N; Ribuot C; Lamontagne D; Nadeau R; Couture R
    Br J Pharmacol; 1993 Sep; 110(1):71-6. PubMed ID: 8220916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1.
    deBlois D; Bouthillier J; Marceau F
    Br J Pharmacol; 1991 May; 103(1):1057-66. PubMed ID: 1878745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Components of kallikrein-kinin system in experimental and clinical neuroallergy].
    Kozlova LS; Trapezontseva RA; Vilkov GA
    Vopr Med Khim; 1982; 28(3):131-4. PubMed ID: 6920947
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assays for kinins using high-affinity monoclonal kinin antibodies.
    Odya CE; Lee CH
    Biochem Pharmacol; 1990 Jul; 40(2):245-51. PubMed ID: 2375767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
    Majima M; Jin HY; Katori M; Sunahara N
    Agents Actions Suppl; 1992; 38 ( Pt 3)():467-74. PubMed ID: 1462880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.